長期COVID病原性における補足体の役割
Rafael Bayarri-Olmos1,2,3, William Bain4,5, Akiko Iwasaki1,2,3
1Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
JCI insight
|August 26, 2025
まとめ
SARS-CoV-2感染後の慢性的な状態であるロング・COVIDには,日常生活に影響を与えるさまざまな症状が含まれています. 補完体系の異常が 病理を誘発する可能性があることが 示唆されています
科学分野:
- 免疫学
- 感染症
- 病理学について
背景:
- ロング・COVIDは,SARS-CoV-2感染後の慢性的な多系統性疾患である.
- 感染者の少なくとも10%は 日常生活や仕事に影響を及ぼします
- ロング・COVIDの根本的なメカニズムはまだよくわかっていません.
研究 の 目的:
- 補完体系の不調をロング・COVIDと結びつける証拠を検証する.
- ロング・COVIDの病原性におけるコンプリメンタル・システムの役割を調査する.
主な方法:
- 最近の研究の文献レビュー
- 免疫反応と病気の病理学に関する研究の検討
主要な成果:
- 最近の研究では,補完体系の調節不全がロング・COVIDに関連していることが示唆されています.
- この不調は凝固,炎症,血管損傷に関連している可能性があります.
結論:
- コンプリメントシステムの不調は ロング・COVIDに寄与する可能性がある.
- 病理学におけるその役割を完全に解明するには,さらなる研究が必要である.
関連する概念動画
Complement System
2.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
COPD: Pathogenesis and Clinical Features
517
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
517
Pneumonia II: Pathophysiology
549
The pathophysiology of pneumonia involves the following steps:
549
Antimicrobial Proteins
5.1K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
5.1K
Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


